Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition | Synapse

May 20, 2020Open Access

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition

Key Points

Key points are not available for this paper at this time.

Abstract

Use of BRAF inhibition results in robust and durable responses in BRAF V600E-mutated PLGG. Prospective studies are required to determine long-term survival and functional outcomes with BRAF inhibitor therapy in childhood gliomas.

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Nobre et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd61ee0a7b4bc8c4101e7f https://doi.org/https://doi.org/10.1200/po.19.00298

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas2017 · 345 citations
2Inhibition of Mutated, Activated BRAF in Metastatic Melanoma2010 · 3,535 citations
3Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas1997 · 639 citations
4BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas2008 · 517 citations
5Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction2015 · 348 citations